DESC:Field of the Invention:
The present invention relates to the field of medical devices and more specifically to intravenous (IV) therapy equipment. It addresses innovations in IV line kits designed to reduce the risk of catheter-related bloodstream infections (CRBSIs) and sepsis. The invention incorporates antimicrobial materials, advanced monitoring technologies, and enhanced safety features aimed at improving patient outcomes and ensuring safer administration of intravenous fluids and medications in healthcare settings.
Background of the Invention:
Intravenous (IV) therapy is a critical component of modern medical care, allowing for the rapid delivery of fluids, medications, and nutrients directly into a patient’s bloodstream. Despite its widespread use, IV therapy is associated with significant risks, particularly catheter-related bloodstream infections (CRBSIs), which can lead to sepsis – a life-threatening condition characterized by the body’s extreme response to infection.
Current IV-line kits, while effective in delivering fluids, often lack integrated features to proactively prevent infection. Traditional designs rely heavily on manual handling, which increases the risk of contamination. Additionally, the absence of continuous monitoring mechanisms leaves healthcare providers reliant on periodic inspections, which may delay the detection of early infection indicators.
One of the primary challenges in preventing CRBSIs is the frequent need to access and manipulate the IV line for medication administration and fluid changes. Each interaction introduces potential microbial contamination, despite adherence to strict aseptic protocols. Moreover, biofilm formation on the internal surfaces of IV catheters is a persistent issue that conventional kits fail to adequately address.
Furthermore, the complexity and variability of existing IV-line kits contribute to inconsistencies in their use across healthcare settings. This variability can result in user error, further exacerbating infection risks.
Thus, there is a pressing need for an innovative IV-line kit that integrates antimicrobial technologies, automated monitoring, and user-friendly features to minimize infection risks and enhance patient safety. The present invention seeks to address these limitations by providing a comprehensive solution that actively prevents contamination and facilitates early detection of potential issues, thereby reducing the incidence of sepsis and improving overall patient outcomes.
Summary of the Invention:
The present invention relates to an Innovative Intravenous (IV) Line Kit designed to prevent catheter-related bloodstream infections (CRBSIs) and reduce the risk of sepsis during intravenous therapy. This invention introduces a comprehensive solution that combines antimicrobial protection, advanced monitoring capabilities, and intuitive design features to enhance patient safety and improve clinical outcomes.
The IV line kit incorporates antimicrobial coatings on all internal and external surfaces to inhibit bacterial growth and biofilm formation. Additionally, the invention features self-sealing connectors that minimize exposure to contaminants during fluid changes and medication administration.
A key aspect of the invention is the integration of a real-time monitoring system equipped with sensors to track fluid flow, temperature, and pressure within the IV line. This system detects irregularities that could indicate contamination, occlusion, or fluid leakage, triggering alerts for immediate intervention by healthcare providers.
The kit also includes single-use disposable components to eliminate the risk of cross-contamination between patients. Its ergonomic design features color-coded parts and simplified assembly, ensuring ease of use and reducing the likelihood of human error during setup and operation.
By addressing the limitations of traditional IV line kits, this invention aims to:
• Significantly reduce infection rates and the incidence of sepsis.
• Enhance operational efficiency for healthcare professionals.
• Improve patient outcomes by providing a safer and more reliable IV therapy system.
This innovative solution is applicable across a wide range of healthcare environments, including hospitals, intensive care units (ICUs), emergency departments, and home healthcare settings.
Detailed Description of the Invention:
The present invention discloses an Innovative Intravenous (IV) Line Kit designed to minimize infection risks, reduce sepsis incidence, and enhance overall patient safety during intravenous therapy. The kit integrates antimicrobial technology, advanced monitoring systems, and user-friendly design features to address the limitations of conventional IV line kits.
1. Components of the IV Line Kit:
1. IV Catheter and Tubing with Antimicrobial Coating:
o The catheter and tubing are coated with a biocompatible antimicrobial agent (such as silver nanoparticles or chlorhexidine) that prevents bacterial colonization and biofilm formation.
o The antimicrobial layer extends along the entire length of the tubing and catheter, providing continuous protection during fluid administration.
2. Self-Sealing Connectors and Ports:
o The connectors feature a self-sealing mechanism that automatically closes after disconnection, minimizing the risk of contamination during fluid changes or medication administration.
o The design reduces the need for manual capping, streamlining workflow and enhancing aseptic technique.
3. Integrated Real-Time Monitoring System:
o The system includes micro-sensors embedded within the tubing to monitor fluid flow rate, temperature, and internal pressure.
o Any irregularities (e.g., occlusion, leakage, or changes in temperature) trigger visual and audible alarms, prompting immediate corrective action by healthcare providers.
o Data collected by the sensors can be transmitted wirelessly to hospital monitoring systems or handheld devices.
4. Disposable Single-Use Components:
o Key parts of the kit, including connectors and valves, are designed for single-use to eliminate cross-contamination risks.
o After use, these components can be safely disposed of following standard medical waste protocols.
5. User-Friendly Assembly and Color-Coded Design:
o The kit features color-coded tubing and connectors to simplify assembly and ensure proper line connections.
o A step-by-step guide with diagrams is included to facilitate correct setup by medical staff, reducing the risk of user error.
2. Embodiments of the Invention:
Embodiment 1 – Basic Kit for Standard IV Therapy:
• This embodiment includes antimicrobial tubing, a self-sealing port, and a single-lumen catheter for use in routine intravenous therapy in non-critical care settings.
Embodiment 2 – Advanced Kit for Critical Care and ICU Use:
• In this embodiment, the IV line kit features a multi-lumen catheter, advanced sensor integration, and wireless monitoring capabilities. It is designed for use in intensive care units (ICUs) where patients are at a higher risk of infection.
Embodiment 3 – Portable IV Line Kit for Home Healthcare:
• This version is adapted for home healthcare applications, including a simplified monitoring system that connects to a patient’s smartphone for remote tracking by healthcare providers.
3. Methods of Implementation:
Step 1 – Preparation and Setup:
• The healthcare provider selects the appropriate IV line kit based on the patient's condition and medical requirements.
• The catheter is inserted using aseptic techniques, and the tubing is connected following the color-coded guide.
Step 2 – Activation and Monitoring:
• Upon initiation of IV therapy, the monitoring system is activated to continuously track flow rate and other critical parameters.
• Any detected anomalies prompt immediate notifications.
Step 3 – Maintenance and Replacement:
• Disposable components are replaced at specified intervals or as necessary.
• Regular data logs from the monitoring system assist healthcare teams in evaluating IV line performance and patient condition.
Material Composition:
The IV tubing in the Innovative IV Line Kit is constructed from medical-grade polyurethane (PU) and silicone elastomer, chosen for their biocompatibility, flexibility, and strength. These materials ensure that the tubing is:
• Non-toxic and Non-reactive – Safe for prolonged contact with bodily fluids and medications.
• Latex-Free – Suitable for patients with latex allergies.
• Kink-Resistant – Maintains fluid flow even under bending or pressure.
• Transparent – Allows visual inspection of the fluid path to detect air bubbles or blockages.
Additionally, the outer layer of the tubing is coated with silver-ion infused antimicrobial material, preventing bacterial colonization and biofilm formation along the internal and external surfaces.
Durability and Performance:
The tubing is engineered to withstand:
• High Pressure (up to 300 psi) – Suitable for rapid fluid administration and use with infusion pumps.
• Temperature Variations – Operates effectively between 5°C to 45°C without material degradation.
• Chemical Resistance – Compatible with a wide range of IV fluids, medications, and disinfectants without leaching or cracking.
• Long-Term Use – Designed for continuous use for up to 7 days under standard hospital conditions without compromising performance.
The tubing’s outer layer also features UV stabilization, preventing material breakdown from light exposure during transport and storage.
Antimicrobial Properties of IV Tubing:
The IV tubing in the Innovative IV Line Kit incorporates advanced antimicrobial technology to prevent catheter-related bloodstream infections (CRBSIs) and minimize the risk of sepsis. The antimicrobial properties are achieved through silver-ion infusion and chlorhexidine coating, which actively inhibit microbial growth along the internal and external surfaces of the tubing.
1. Antimicrobial Agents Used:
a. Silver-Ion Infusion:
• Mechanism: Silver ions (Ag?) disrupt bacterial cell membranes, interfere with DNA replication, and inhibit essential enzyme activity, ultimately leading to cell death.
• Broad-Spectrum Efficacy: Effective against Gram-positive and Gram-negative bacteria, fungi, and some viruses.
• Long-Lasting Protection: The silver ions continuously release over time, providing sustained antimicrobial activity for the duration of catheter use.
b. Chlorhexidine Coating (Optional):
• Mechanism: Chlorhexidine disrupts microbial cell walls and precipitates cytoplasmic proteins, causing cell lysis.
• Localized Action: Chlorhexidine remains active at the surface of the tubing, preventing biofilm formation without systemic absorption.
• Proven Effectiveness: Demonstrated to reduce catheter colonization by up to 70% in clinical settings.
2. Tubing Structure with Antimicrobial Layers:
• Outer Layer: Infused with silver nanoparticles to prevent external contamination from handling or environmental exposure.
• Inner Layer: Coated with chlorhexidine to prevent microbial colonization within the fluid path.
• Intermediate Layer (Optional): Embedded with additional antimicrobial agents that activate when exposed to moisture, providing redundancy.
3. Key Benefits of Antimicrobial Tubing:
• Reduced Biofilm Formation: Biofilms can harbor bacteria and are resistant to antibiotics. Antimicrobial coatings prevent the initial attachment of microbes, reducing biofilm buildup.
• Decreased Risk of CRBSIs: By minimizing bacterial colonization, the tubing significantly lowers the risk of bloodstream infections, a leading cause of sepsis in hospitalized patients.
• Extended Catheter Lifespan: Antimicrobial tubing can safely remain in place for longer durations without increasing infection risk.
4. Testing and Validation:
• The antimicrobial efficacy of the tubing is validated through:
o Zone of Inhibition (ZOI) Tests: Measures the area around the tubing where bacterial growth is prevented.
o Colony-Forming Unit (CFU) Reduction Tests: Quantifies the reduction in bacterial load on treated versus untreated tubing.
o Real-World Clinical Trials: Conducted in ICU settings, demonstrating a 40-60% reduction in infection rates compared to standard IV tubing.
Sensor Data Transmission Process:
The Innovative IV Line Kit integrates a real-time monitoring system equipped with sensors embedded within the tubing and connectors. These sensors track critical parameters, including fluid flow rate, temperature, and internal pressure. The data transmission process involves the following steps:
1. Data Collection by Sensors:
• Micro-sensors continuously collect real-time data on fluid dynamics and environmental conditions within the IV line.
• Parameters monitored include:
o Flow Rate – Ensures consistent delivery of fluids or medication.
o Pressure – Detects occlusions, blockages, or leaks.
o Temperature – Identifies temperature deviations that could signal infection or fluid irregularities.
2. Signal Processing and Data Conversion:
• The raw data from the sensors is processed by an embedded microcontroller located within the IV kit’s hub.
• The analog sensor signals are converted into digital data for further analysis.
• The microcontroller filters and validates the data, discarding false readings and ensuring accuracy.
3. Wireless Data Transmission:
• The processed data is transmitted wirelessly using Bluetooth Low Energy (BLE) or Near Field Communication (NFC) technology.
• For critical care settings, the system may utilize Wi-Fi or RFID (Radio Frequency Identification) for long-range communication.
• Data packets are encrypted to ensure secure transmission and protect patient privacy.
4. Data Reception by Monitoring Devices:
• The transmitted data is received by hospital monitoring systems, handheld devices, or wearable devices used by healthcare providers.
• In home healthcare environments, data can be received by a patient’s smartphone or tablet via a dedicated application.
5. Alert and Notification System:
• If the system detects irregularities (e.g., blocked flow, high pressure, or abnormal temperature), it triggers real-time alerts.
• Alerts are sent to the designated healthcare provider through:
o Text Messages / Push Notifications
o Audible and Visual Alarms on bedside monitors
o Email Reports for remote caregivers
6. Data Logging and Historical Analysis:
• All sensor data is logged and stored in a cloud-based platform or local server for future analysis.
• Historical data allows medical teams to track trends, optimize treatment protocols, and make data-driven decisions.
Example Workflow:
• A patient in the ICU receives IV therapy through the kit.
• Sensors detect a pressure build-up indicating a partial occlusion.
• The system immediately transmits an alert to the nurse’s station and the patient's bedside monitor.
• A nurse is notified, intervenes, and resolves the issue before complications arise.
Sensor Calibration Process for IV Line Kit:
Calibration of the sensors embedded in the Innovative IV Line Kit ensures accurate and reliable data collection, minimizing false alerts and maintaining the precision required for patient safety. The calibration process involves several stages to account for environmental factors, fluid variations, and sensor drift over time.
1. Initial Factory Calibration:
• Each sensor undergoes calibration at the manufacturing stage using controlled conditions.
• The sensors are tested with:
o Standardized IV fluids at known flow rates and pressures.
o Temperature-controlled environments to validate heat sensitivity.
• Calibration values are stored in the sensor’s microcontroller as reference points for future recalibration.
2. Automatic Self-Calibration (During Use):
• The system is equipped with an auto-calibration feature that periodically recalibrates sensors while the IV line is in operation.
• Baseline measurements are taken during initial fluid administration, establishing a point of reference for normal operation.
• Any deviation from the baseline triggers recalibration or alerts the user if the variance exceeds acceptable thresholds.
3. Manual Calibration by Healthcare Staff:
• Manual calibration modes are available for healthcare professionals through a connected device or app.
• The provider can initiate calibration by flushing the IV line with a calibration solution (saline) or by inputting specific flow rates and fluid volumes.
• The system prompts the user to confirm stable readings, adjusting sensor sensitivity as needed
4. Environmental Compensation:
• Sensors are equipped with temperature and humidity compensators that adjust readings based on environmental fluctuations.
• The system automatically corrects for slight pressure changes caused by altitude, room temperature, or patient movement.
5. Error Detection and Recalibration:
• If irregular sensor behavior is detected (e.g., inconsistent pressure readings or flow interruptions), the system prompts recalibration.
• In cases where recalibration fails, the system notifies the healthcare provider to replace the affected component.
Calibration Verification Test (CVT):
• A Calibration Verification Test is performed monthly or after extended periods of non-use.
• This involves running a simulation using a dummy IV bag that mimics typical flow and pressure conditions. The system compares measured data to expected values, ensuring all sensors operate within specified tolerances.
Example Workflow:
• A new IV line kit is opened and connected to the patient.
• During the first 5 minutes of fluid flow, the system performs automatic calibration.
• After one week, the system triggers a self-calibration cycle to account for potential sensor drift.
• A nurse performs manual calibration by flushing the IV line with saline after medication delivery.
,CLAIMS:1. Independent Claims:
1. An intravenous (IV) line kit for sepsis prevention and patient safety, comprising:
o A catheter with an internal lumen for fluid delivery, coated with an antimicrobial layer to inhibit bacterial colonization and biofilm formation;
o Flexible medical-grade tubing with an antimicrobial coating along its internal and external surfaces;
o A self-sealing connector equipped with an automatic valve mechanism that prevents fluid leakage and minimizes exposure to contaminants;
o Embedded micro-sensors within the tubing configured to monitor fluid flow rate, temperature, and pressure in real time;
o A wireless data transmission module that transmits sensor data to external monitoring devices;
o An alert system that notifies healthcare providers upon detecting irregularities in flow, pressure, or temperature.
2. The IV line kit of claim 1, wherein the antimicrobial layer comprises silver-ion infusion or chlorhexidine coating.
3. The IV line kit of claim 1, wherein the tubing is made from polyurethane or silicone elastomer, providing flexibility, durability, and kink resistance.
4. The IV line kit of claim 1, wherein the micro-sensors are calibrated to detect flow interruptions, occlusions, and leakage.
2. Dependent Claims:
5. The IV line kit of claim 1, wherein the wireless data transmission module uses Bluetooth Low Energy (BLE) or Wi-Fi for seamless integration with hospital monitoring systems.
6. The IV line kit of claim 1, wherein the self-sealing connector is configured to automatically close upon disconnection, minimizing contamination risk.
7. The IV line kit of claim 1, wherein the tubing’s outer surface is coated with a UV-stabilized antimicrobial layer to prevent degradation during storage and use.
8. The IV line kit of claim 1, wherein the system is compatible with infusion pumps operating at pressures up to 300 psi.
9. The IV line kit of claim 4, wherein the alert system provides visual, audible, and digital notifications to healthcare personnel through handheld devices.
10. The IV line kit of claim 1, further comprising disposable, single-use connectors and valves to eliminate cross-contamination risks between patients.
11. The IV line kit of claim 1, wherein the micro-sensors are capable of logging data to a cloud-based platform for remote monitoring and historical analysis.